Dicloxacillin Sodium

Product NDC: 0440-7380
11-digit product format: 004407380
Labeler code: 0440
Product ID: 0440-7380_1f007574-56f1-4695-be3a-aeb85c41d466
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Dicloxacillin Sodium
Dosage form: CAPSULE
Route: ORAL
Labeler: Liberty Pharmaceuticals, Inc.
Application: ANDA062286
Marketing category: ANDA
Marketing start: 1990-09-30
Marketing end: 0000-00-00
Substance: DICLOXACILLIN SODIUM
Active strength: 250 mg/1
Pharmacologic classes: Penicillin-class Antibacterial [EPC],Penicillins [CS]
NDC exclude flag: E
Listing certified through: 2018-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0440-7380		I	Inactivated by FDA		2026-08-03
excluded package	package	0440-7380	0440-7380-40	I	Inactivated by FDA		2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 44 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0440-7380-40	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0440-7380-40	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0440-7380-40	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0440-7380-40	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0440-7380-40	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0440-7380-40	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0440-7380-40	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0440-7380-40	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0440-7380-40	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0440-7380-40	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0440-7380-40	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0440-7380-40	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	0440-7380-40	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	0440-7380-40	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	0440-7380-40	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	0440-7380-40	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	0440-7380-40	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	0440-7380-40	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	0440-7380-40	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	0440-7380-40	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded product	product		I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2020-06-10 20:45 UTC · source 2020-06-10	excluded package	package	0440-7380-40	I	Inactivated by FDA	`9bebd1f3094a…`	`5416666fcb17…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`
2019-12-08 06:16 UTC · source 2019-12-05	excluded package	package	0440-7380-40	E	Excluded after deficient or non-compliant submission was not corrected	`110d247fa046…`	`a55b01930146…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A062286-001	DICLOXACILLIN SODIUM	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03
A062286-002	DICLOXACILLIN SODIUM	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A062286-001	AB
A062286-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 82 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB	RS	1982-06-03	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL			1982-06-03	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL		RS	1982-06-03	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL			1982-06-03	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL		RS	1982-06-03	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL			1982-06-03	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL		RS	1982-06-03	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL	AB		1982-06-03	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL	AB		1982-06-03	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL			1982-06-03	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL		RS	1982-06-03	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A062286-001	DICLOXACILLIN SODIUM	EQ 250MG BASE	CAPSULE / ORAL			1982-06-03	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A062286-002	DICLOXACILLIN SODIUM	EQ 500MG BASE	CAPSULE / ORAL		RS	1982-06-03	`782e0a99824c…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 63 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A062286-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062286-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062286-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062286-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062286-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062286-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062286-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062286-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062286-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062286-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062286-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062286-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062286-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062286-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062286-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062286-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062286-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062286-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062286-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062286-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062286-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062286-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062286-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062286-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062286-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062286-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062286-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A062286-002	AB	1	`8072bd15b7f6…`
2019-12-13 00:20 UTC	2019-12	A062286-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A062286-002	AB	1	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	A062286-001	AB	1	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	A062286-002	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A062286-001	AB	1	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	A062286-002	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A062286-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	A062286-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A062286-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	A062286-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A062286-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	A062286-002	AB	1	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ce7f6212-eff4-e8f0-b733-f4aa5877dfa0	Product name	2	20231211

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
0440-7380-40	2020-01-31	C162847	48780-1	9d75b9d0-006d-f424-e053-dadaa90a57ce	DICLOXACILLIN SODIUM CAPSULES USP 3123 3125 Rx only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
0440-7380-40	Dicloxacillin Sodium	40 in 1 BOTTLE, PLASTIC	CAPSULE	40		2

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
DICLOXACILLIN SODIUM	ACTIVE INGREDIENT	4HZT2V9KX0	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
DICLOXACILLIN	ACTIVE MOIETY	COF19H7WBK	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
FD&C BLUE NO. 2	INACTIVE INGREDIENT	L06K8R7DQK	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
SHELLAC	INACTIVE INGREDIENT	46N107B71O	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
SORBITAN MONOLAURATE	INACTIVE INGREDIENT	6W9PS8B71J	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0440-7380	DICLOXACILLIN SODIUM CAPSULE [LIBERTY PHARMACEUTICALS, INC.]	2	Legacy NDC, 1 package rows	20130909_939f13c5-c394-49c1-ae57-edc44438a9de.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
DICLOXACILLIN SODIUM	DICLOXACILLIN SODIUM	Chartwell RX, LLC	270c0839-c30c-475d-a505-e70855652c9e	2026-07-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062286 application number: ANDA062286
Dicloxacillin Sodium	DICLOXACILLIN SODIUM	PD-Rx Pharmaceuticals, Inc.	c17cd62d-ff5d-47ba-8673-3346c7f2365f	2026-05-21	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062286 application number: ANDA062286
Dicloxacillin Sodium	DICLOXACILLIN SODIUM	PD-Rx Pharmaceuticals, Inc.	9e2bbe03-44cb-45d1-acdb-b61d9016055e	2025-10-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062286 application number: ANDA062286
Dicloxacillin Sodium	DICLOXACILLIN SODIUM	PD-Rx Pharmaceuticals, Inc.	24e821aa-85b8-4f5a-aa13-83ff132952ca	2025-10-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062286 application number: ANDA062286
Dicloxacillin Sodium	DICLOXACILLIN SODIUM	Bryant Ranch Prepack	3e4842ec-773b-4aeb-b37d-1c4e3cf53424	2024-01-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062286 application number: ANDA062286
Dicloxacillin Sodium	DICLOXACILLIN SODIUM	Teva Pharmaceuticals USA, Inc.	8478f242-c715-4984-ac1d-dc79dc28665e	2022-06-22	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062286 application number: ANDA062286
Dicloxacillin Sodium	DICLOXACILLIN SODIUM	Asclemed USA, Inc.	a4174fda-68f7-4834-be58-dd6b167cf9f0	2020-11-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062286 application number: ANDA062286

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4HZT2V9KX0	DICLOXACILLIN SODIUM	13412-64-1	DICLOXACILLIN SODIUM

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197595	dicloxacillin sodium 250 MG Oral Capsule	PSN	939f13c5-c394-49c1-ae57-edc44438a9de	2
197595	dicloxacillin 250 MG Oral Capsule	SCD	939f13c5-c394-49c1-ae57-edc44438a9de	2
197595	dicloxacillin (as dicloxacillin sodium) 250 MG Oral Capsule	SY	939f13c5-c394-49c1-ae57-edc44438a9de	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
0440-7380-40	00440738040	40 in 1 BOTTLE, PLASTIC	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
DICLOXACILLIN SODIUM CAPSULES USP 3123 3125 Rx only	Liberty Pharmaceuticals, Inc.	2013-09-06	HUMAN PRESCRIPTION DRUG LABEL	2